Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - rabbit antithymocyte immunoglobulin, quantity: 25 mg - injection, powder for - excipient ingredients: sodium chloride; glycine; mannitol - thymoglobuline (rabbit anti-human thymocyte immunoglobulin) is indicated for the prophylaxis of graft rejection in renal transplantation; treatment of steroid-resistant or moderate to severe renal transplant rejection: and treatment of refractory or relapsing aplastic anaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide, quantity: 20 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; povidone; colloidal anhydrous silica; magnesium stearate; crospovidone; hypromellose; macrogol 8000; titanium dioxide; purified talc; iron oxide yellow - arabloc is indicated for the treatment of: active rheumatoid arthritis. active psoriatic arthritis. arabloc is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. the combined use of arabloc with other disease modifying anti-rheumatic drugs (dmards) has not been adequately studied (see precautions).

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; povidone; colloidal anhydrous silica; magnesium stearate; crospovidone; hypromellose; macrogol 8000; titanium dioxide; purified talc - arabloc is indicated for the treatment of: active rheumatoid arthritis. active psoriatic arthritis. arabloc is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. the combined use of arabloc with other disease modifying anti-rheumatic drugs (dmards) has not been adequately studied (see precautions).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nsw department of primary industries - rabbit haemorrhagic disease virus - wettable powder - rabbit haemorrhagic disease virus biological-virus active 3000.0 ld50/ml - vertebrate poison - preparation of baits - european rabbit

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - inactivated rabbit calicivirus disease virus; thiomersal - misc. vaccines or anti sera - inactivated rabbit calicivirus disease virus vaccine-viral active 2560.0 hau/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - rabbit - european - rabbit calicivirus disease

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

csiro sustainable ecosystems - rabbit calicivirus - parenteral liquid/solution/suspension - rabbit calicivirus biological-virus active 3000.0 ld50/ml - vertebrate poison - rabbit warren - rabbit

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - rabies virus -

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmagal bio s.r.o - rabbit haemorrhagic disease virus, strain phb 98 - suspension for injection - 1 - rabbit haemorrhagic disease virus vaccine - rabbits - immunological - inactivated vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmagal bio s.r.o - rabbit haemorrhagic disease, strain rhdv phb 98 - suspension for injection - minimum 1 pd90 - rabbit haemorrhagic disease virus - rabbits - immunological - inactivated vaccine

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide -